ArcMesa Educators
ArcMesa Educators
 
home about courses contact July 03, 2009
Theraputic Areas
Cardiology
Neurology
Nursing
Oncology
Osteoporosis
Pharmacy
cme podcast
CME podcast

ACS Patients and Antiplatelet Resistance antiplatelet resistanceACS Patients and Antiplatelet Resistance: Where We Are and Where We're Going.
Faculty: Deepak L. Bhatt, MD | Cindy L. Grines, MD | Peter B. Berger, MD
CME / CE credit hour: 1.5
Myocardial ischemia secondary to acute restrictions in coronary artery blood flow leads to acute coronary syndromes (ACS). Dual antiplatelet therapy with aspirin and clopidogrel is the standard of care for patients with ACS. However, resistance to these agents is associated with adverse clinical events, and is of great concern to clinicians. This educational program will review clinical data pertinent to the current state of antiplatelet therapy for the management of patients with ACS.
CME / CE  
Copyright © 2009 ArcMesa Educators, LLC. All Rights Reserved. | Privacy Statement

All information content within shall be considered confidential property of ArcMesa Educators, LLC
and should not be disclosed or redistributed to third parties without express permission.